Evaluation of the objective Posturo-Locomotor-Manual (PLM) method in patients with Parkinsonian syndromes

Evaluation of the objective Posturo-Locomotor-Manual (PLM) method in patients with Parkinsonian syndromes

AbstractObjective methods for quantifying patients' movement capacity would be valuable for evaluating progression and interventions in neurodegenerative diseases. The Posturo-Locomotor-Manual (PLM) test is a standardized automated movement test developed for the evaluation of hypokinetic sy...

Full description

Bibliographic Details
Main Authors:	Theresa eZackrisson, Filip eBergquist, Björn eHolmberg, Bo eJohnels, Thorleif eThorlin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-07-01
Series:	Frontiers in Neurology
Subjects:	Movement Disorders Parkinson's disease parkinsonism L-DOPA test optoelectronic movement analysis PLM test
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fneur.2013.00095/full

Similar Items

Predictive Value of Ambulatory Objective Movement Measurement for Outcomes of Levodopa/Carbidopa Intestinal Gel Infusion
by: Gökçe Kilinçalp, et al.
Published: (2022-01-01)

7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate
by: M. T. Herrero, et al.
Published: (2023-05-01)

End-of-life design aid in PLM environment using agent technology
by: J. Diakun, et al.
Published: (2020-04-01)

DDC-Promoter-Driven Chemogenetic Activation of SNpc Dopaminergic Neurons Alleviates Parkinsonian Motor Symptoms
by: Dong-Chan Seo, et al.
Published: (2023-01-01)

The Effect of L-dopa on Postural Stability in Parkinson’s Disease Patients
by: Jacek Wilczyński, et al.
Published: (2019-01-01)

Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys
by: Marc Morissette, et al.
Published: (2022-02-01)

Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats
by: Stefania eSgroi, et al.
Published: (2014-10-01)

Amino Acid Management of Parkinson’s Disease: A Case Study [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Amino Acid Management of Parkinson’s Disease: a Case Study [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice
by: Daniel Marcellino, et al.
Published: (2010-11-01)

The level of observed physical movement accompanying periodic limb movements measured in a clinical sleep population
by: Hooper RG
Published: (2018-04-01)

Camera-based objective measures of Parkinson’s disease gait features
by: Jannis van Kersbergen, et al.
Published: (2021-08-01)

Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes
by: Lior eGreenbaum, et al.
Published: (2015-02-01)

Study on PLM and Big Data Collection for the Digital Transformation of the Shipbuilding Industry
by: Sangil Park, et al.
Published: (2022-10-01)

Verbal auditory cueing of improvisational dance: A proposed method for training agency in Parkinson’s disease
by: Glenna eBatson, et al.
Published: (2016-02-01)

PLM-COMPETENCE FORMATION USING COMPUTATIONAL-GRAPHICAL PRACTICE
by: Vladimir V. Zelentsov, et al.
Published: (2016-05-01)

Movement context modulates neuronal activity in motor and limbic-associative domains of the human parkinsonian subthalamic nucleus
by: Odeya Marmor, et al.
Published: (2020-03-01)

Virtual enterprise based on the Lotsman PLM SYSTEM as a multi-agent system
by: D. V. Koshutin
Published: (2020-08-01)

Baseline Wander Removal Applied to Smooth Pursuit Eye Movements From Parkinsonian Patients
by: Mehdi Bejani, et al.
Published: (2023-01-01)

Influence of depressive symptoms on dopaminergic treatment of Parkinson’s disease
by: Alexandru eHanganu, et al.
Published: (2014-09-01)

Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson’s disease
by: Sandy eStayte, et al.
Published: (2014-08-01)

Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
by: Sandy eStayte, et al.
Published: (2014-05-01)

Therapeutics of parkinson's disease and other movement disorders /
by: Hallett, Mark, et al.
Published: (2008)

Detecting Parkinson’s Disease Using Machine Learning from Movement
by: Emma Richard, et al.
Published: (2023-11-01)

Pilates Exercise and Functional Balance in Parkinson\'s Disease
by: Babak Bakhshayesh, et al.
Published: (2017-02-01)

Pattern and frequency of involuntary movements: hospital-based study
by: H. N. El Tallawy, et al.
Published: (2023-07-01)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion. A possible compensatory mechanism in Parkinson’s disease
by: Javier eBlesa, et al.
Published: (2011-11-01)

Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
by: Yu Zhang, et al.
Published: (2023-02-01)

Atypical parkinsonism and self‐mutilation: A new lens on the old concept
by: Mehri Salari, et al.
Published: (2021-11-01)

Towards GreenPLM—Key Sustainable Indicators Selection and Assessment Method Development
by: Joanna Helman, et al.
Published: (2023-01-01)

Directional Monopole Antenna Using a Planar Lossy Magnetic (PLM) Surface
by: Jae-Gon Lee
Published: (2023-07-01)

A smartphone-based system to quantify dexterity in Parkinson's disease patients
by: Somayeh Aghanavesi, et al.
Published: (2017-01-01)

Characterization and toxicity of zinc aluminium layered double hydroxide-levodopa nanocomposite
by: Kura, Aminu Umar
Published: (2014)

The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia
by: Mitchell J. Bartlett, et al.
Published: (2020-12-01)

Management of L-Dopa Overdose in the Competitive Inhibition State [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA
by: Banashree Mondal, et al.
Published: (2019-01-01)

Comparative study of clinical profile between familial and sporadic Parkinson's disease
by: Anis Jukkarwala
Published: (2017-07-01)

Management of L-Dopa Overdose in the Competitive Inhibition State [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Centrality of striatal cholinergic transmission in basal ganglia function
by: Paola eBonsi, et al.
Published: (2011-02-01)

Stroke Damage Detection Using Classification Trees on Electrical Bioimpedance Cerebral Spectroscopy Measurements
by: Thorleif Thorlin, et al.
Published: (2013-08-01)